Literature DB >> 17956580

Immune reconstitution in human immunodeficiency virus type 1-infected children with different virological responses to anti-retroviral therapy.

A Anselmi1, D Vendrame, O Rampon, C Giaquinto, M Zanchetta, A De Rossi.   

Abstract

Immune repopulation, despite virological failure, often occurs in children under highly active anti-retroviral therapy (HAART). The aim of this study was to analyse the characteristics of immune repopulation and activation in children with and without virological response to HAART. Fourteen human immunodeficiency virus type 1 (HIV-1)-infected children with suppression of HIV-1 plasma viraemia (virological responders, VR) and 16 virological non-responders (VNR) to therapy were studied at baseline and after approximately 2 years of HAART. During therapy, CD4+ T cells increased in both groups, but were higher in the VR than in the VNR group. All CD4+ T cell subsets (naive, central memory, effector/memory and CD38+) increased significantly in VR children, while there was a significant increase only in naive cells in VNR children. Naive CD8+ T cells and T cell receptor rearrangement excision circles (TREC), an indicator of thymic output, increased in both VR and VNR children. Activated CD8+ CD38+ T cells decreased in VR but remained high in VNR children. Levels of circulating lipopolysaccharide (LPS), an indicator of microbial translocation, further increased in VNR children. In conclusion, HAART induced an increase in naive cells in all children, regardless of their virological response. However, the persistence of viraemia resulted in an impaired expansion of memory CD4+ T cells susceptible to HIV-1 infection, and together with the microbial translocation sustained the persistence of a high level of immune activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17956580      PMCID: PMC2219365          DOI: 10.1111/j.1365-2249.2007.03526.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  43 in total

1.  Sustained viral suppression and immune recovery in HIV type 1-infected children after 4 years of highly active antiretroviral therapy.

Authors:  Pieter L A Fraaij; Gwenda Verweel; Annemarie M C van Rossum; Ellen G van Lochem; Martin Schutten; Corry M R Weemaes; Nico G Hartwig; David M Burger; Ronald de Groot
Journal:  Clin Infect Dis       Date:  2005-01-25       Impact factor: 9.079

2.  Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.

Authors:  M de Martino; M E Rossi; C Azzari; M G Gelli; L Galli; A Vierucci
Journal:  Pediatr Res       Date:  1998-06       Impact factor: 3.756

3.  Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation.

Authors:  N G Pakker; D W Notermans; R J de Boer; M T Roos; F de Wolf; A Hill; J M Leonard; S A Danner; F Miedema; P T Schellekens
Journal:  Nat Med       Date:  1998-02       Impact factor: 53.440

4.  Immunological response to highly active antiretroviral therapy in children with clinically stable HIV-1 infection.

Authors:  Howard M Rosenblatt; Kenneth E Stanley; Lin Y Song; George M Johnson; Andrew A Wiznia; Sharon A Nachman; Paul A Krogstad
Journal:  J Infect Dis       Date:  2005-06-29       Impact factor: 5.226

5.  Effect of changing antiretroviral therapy on human immunodeficiency virus viral load: experience with fifty-four perinatally infected children.

Authors:  M Purswani; R Johann-Liang; J Cervia; G J Noel
Journal:  Pediatr Infect Dis J       Date:  1999-06       Impact factor: 2.129

6.  Genotypic and phenotypic correlates of the HIV Type 1 env gene evolution in infected children with discordant response to antiretroviral therapy.

Authors:  Patrizia Bagnarelli; Manuela Vecchi; Nicoletta Burighel; Domenico Bellanova; Stefano Menzo; Massimo Clementi; Anita De Rossi
Journal:  AIDS Res Hum Retroviruses       Date:  2004-12       Impact factor: 2.205

7.  Cytomegalovirus rather than HIV triggers the outgrowth of effector CD8+CD45RA+CD27- T cells in HIV-1-infected children.

Authors:  Vincent Bekker; Corine Bronke; Henriëtte J Scherpbier; Jan F Weel; Suzanne Jurriaans; Pauline M E Wertheim-van Dillen; Frank van Leth; Joep M A Lange; Kiki Tesselaar; Debbie van Baarle; Taco W Kuijpers
Journal:  AIDS       Date:  2005-07-01       Impact factor: 4.177

8.  Two-year clinical and immune outcomes in human immunodeficiency virus-infected children who reconstitute CD4 T cells without control of viral replication after combination antiretroviral therapy.

Authors:  Guity Ghaffari; Dominick J Passalacqua; Jennifer L Caicedo; Maureen M Goodenow; John W Sleasman
Journal:  Pediatrics       Date:  2004-10-18       Impact factor: 7.124

9.  Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors.

Authors:  Sumathi Sankaran; Moraima Guadalupe; Elizabeth Reay; Michael D George; Jason Flamm; Thomas Prindiville; Satya Dandekar
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-24       Impact factor: 11.205

10.  Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

Authors:  J V Giorgi; L E Hultin; J A McKeating; T D Johnson; B Owens; L P Jacobson; R Shih; J Lewis; D J Wiley; J P Phair; S M Wolinsky; R Detels
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

View more
  40 in total

Review 1.  Biomarkers of immune dysfunction in HIV.

Authors:  Daniel E Nixon; Alan L Landay
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

2.  Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.

Authors:  Wei Jiang; Michael M Lederman; Peter Hunt; Scott F Sieg; Kathryn Haley; Benigno Rodriguez; Alan Landay; Jeffrey Martin; Elizabeth Sinclair; Ava I Asher; Steven G Deeks; Daniel C Douek; Jason M Brenchley
Journal:  J Infect Dis       Date:  2009-04-15       Impact factor: 5.226

Review 3.  Mucosal immunity in human and simian immunodeficiency lentivirus infections.

Authors:  J M Brenchley
Journal:  Mucosal Immunol       Date:  2013-04-03       Impact factor: 7.313

4.  Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections.

Authors:  Jason M Brenchley; Mirko Paiardini; Kenneth S Knox; Ava I Asher; Barbara Cervasi; Tedi E Asher; Phillip Scheinberg; David A Price; Chadi A Hage; Lisa M Kholi; Alexander Khoruts; Ian Frank; James Else; Timothy Schacker; Guido Silvestri; Daniel C Douek
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

Review 5.  Microbial translocation, immune activation, and HIV disease.

Authors:  Nichole R Klatt; Nicholas T Funderburg; Jason M Brenchley
Journal:  Trends Microbiol       Date:  2012-10-11       Impact factor: 17.079

6.  The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda.

Authors:  Isaac Ssewanyana; Chris A R Baker; Theodore Ruel; Stephanie Bousheri; Moses Kamya; Grant Dorsey; Philip J Rosenthal; Edwin Charlebois; Diane Havlir; Huyen Cao
Journal:  AIDS Res Hum Retroviruses       Date:  2009-01       Impact factor: 2.205

7.  CD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individuals.

Authors:  Alessandra Bandera; Giulio Ferrario; Marina Saresella; Ivana Marventano; Alessandro Soria; Fabio Zanini; Francesca Sabbatini; Monica Airoldi; Giulia Marchetti; Fabio Franzetti; Daria Trabattoni; Mario Clerici; Andrea Gori
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

8.  Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infection.

Authors:  N R Klatt; L D Harris; C L Vinton; H Sung; J A Briant; B Tabb; D Morcock; J W McGinty; J D Lifson; B A Lafont; M A Martin; A D Levine; J D Estes; J M Brenchley
Journal:  Mucosal Immunol       Date:  2010-03-31       Impact factor: 7.313

9.  Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections.

Authors:  Jacob D Estes; Levelle D Harris; Nichole R Klatt; Brian Tabb; Stefania Pittaluga; Mirko Paiardini; G Robin Barclay; Jeremy Smedley; Rhonda Pung; Kenneth M Oliveira; Vanessa M Hirsch; Guido Silvestri; Daniel C Douek; Christopher J Miller; Ashley T Haase; Jeffrey Lifson; Jason M Brenchley
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

Review 10.  Microbial translocation in HIV infection: causes, consequences and treatment opportunities.

Authors:  Netanya G Sandler; Daniel C Douek
Journal:  Nat Rev Microbiol       Date:  2012-08-13       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.